Key result
Delayed cerebral ischemia prevention in aneurysmal subarachnoid hemorrhage remains limited to nimodipine and hemodynamic strategies.
Answers are grounded in this paper and cite their sources.
Aneurysmal subarachnoid hemorrhage is the most devastating form of stroke. Many pathological mechanisms ensue after cerebral aneurysm rupture, including hydrocephalus, apoptosis of endothelial cells and neurons, cerebral edema, loss of blood-brain barrier, abnormal cerebral autoregulation, microthrombosis, cortical spreading depolarization and macrovascular vasospasm. Although studied extensively through experimental and clinical trials, current treatment guidelines to prevent delayed cerebral ischemia is limited to oral nimodipine, maintenance of euvolemia, induction of hypertension if ischemic signs occur and endovascular therapy for patients with continued ischemia after induced hypertension. Future investigations will involve agents targeting vasodilation, anticoagulation, inhibition of apoptosis pathways, free radical neutralization, suppression of cortical spreading depolarization and attenuation of inflammation.
No takes yet. Share an insight, caveat, or question.
Serrone et al. (2015) conducted a review in Aneurysmal subarachnoid hemorrhage. Oral nimodipine, maintenance of euvolemia, induced hypertension, and endovascular therapy was evaluated on Prevention of delayed cerebral ischemia. Current treatments for aneurysmal subarachnoid hemorrhage to prevent delayed cerebral ischemia are limited to oral nimodipine, euvolemia, induced hypertension, and endovascular therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: